Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I have tried to confirm the 50 million shares at .05 cents
FTW said- "The 50 million in shares issuable upon warrant conversion that you cite refer to the warrants outstanding from previous financing and has nothing to do with executive compensation. In addition, this item has been included in filings going back at least to last years 10ksb, so your assumption that we would somehow be voting to approve shares at the shareholder meeting is inaccurate." Is Fut implying that no vote to approve the 50+ million shares will take place? I am not clear on how to interpet the above. Why is the 50+MM figure mentioned as unapproved if the intent is not to approve these shares?
Share
New Message
Please login to post a reply